While the world awaits the approval of a herpes vaccine, a very old vaccine was recently found to offer some protection against this sexually transmitted disease (STD).
As of December 1, 2023, various studies have found the bacillus Calmette-Guérin (BCG) vaccine offers beneficial off-target effects that might impact the recurrence of herpes simplex virus (HSV) infections in certain people.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
